The TREAT-MS Clinical Trial for Multiple Sclerosis (MS) Patients

There is an unmet need to identify if specific treatment strategies during the relapsing-remitting phase of multiple sclerosis (MS) can prevent, delay, or reduce longer-term disability. Currently, there is a lack of evidence-based guidelines to help clinicians and patients determine which treatment strategy is best for an individual with MS. In addition, it is unclear when people with MS, in the setting of breakthrough disease activity, should switch therapies and whether to consider a different first-line therapy or if they should escalate immediately to higher-efficacy therapies.

The TRaditional versus Early Aggressive Therapy for Multiple Sclerosis (TREAT-MS) Trial will help inform patients and the broader healthcare community on whether patients would most benefit from early, possibly more risky aggressive therapy or if starting with a less aggressive (and, often, less risky) therapy, followed by a switch if breakthrough disease activity occurs, is warranted. In addition, this study will help identify if there is a specific patient population or short-term biomarker(s) that is strongly predictive of long-term disability that can result from MS.

The TREAT-MS Trial is a randomized controlled trial that will recruit 900 patients across approximately 45 sites within the United States. In order to be eligible, participants must have relapsing-remitting MS and be between the ages of 18 and 60 years. Participants will need to be eligible for at least one of the higher-efficacy therapies based on screening labs. Participants are not eligible if they have had more than 6 months’ exposure to one or more MS disease-modifying therapies or prior treatment with rituximab, ocrelizumab, alemtuzumab, mitoxantrone, cladribine, or an experimental aggressive therapy.

Participants that meet the eligibility criteria will initially be divided into two groups based on suspected risk(s) for long-term disability. The first group will include those with “high-risk” indicators for aggressive disease versus “low-risk.” Within each group, eligible participants will be randomized 1:1, to either a “higher-efficacy” therapy (i.e., infusible therapies) versus traditional, first-line therapy (injectable and oral therapies). Participants and their neurology specialist will choose the therapy within the category that participants are randomized to that is most appropriate for them. Those deemed at low risk for disability who are initially randomized to a traditional therapy and who experience breakthrough disease activity will be re-randomized to a higher-efficacy therapy or to a different traditional therapy. An extremely important goal for any intervention is to help improve or maintain a high quality of life; therefore, in addition to classic clinical endpoints (i.e., slowing disability progression), patient-reported outcomes will be obtained in order to gain a better understanding of the full impact of a treatment. Study participation will range from 42 – 54 months, depending on enrollment date and study related activities will occur around a participant’s standard of care visits.

For more information on the TREAT-MS trial, please email the team at Johns Hopkins at This email address is being protected from spambots. You need JavaScript enabled to view it. and we will connect you with a participating site in your area.

Principal Investigators: Ellen M. Mowry, MD, MCR & Scott D. Newsome, DO

Sponsor: Johns Hopkins University School of Medicine

Application No: IRB00143534 

For a complete list of participating sites and contact information: ClinicalTrials.gov

To know more about Multiple Sclerosis:

TREAT-MS Sites

Site Principal Investigator Contact
University of Alabama at Birmingham
Birmingham, AL
William Meador, MD Christie Lowe
This email address is being protected from spambots. You need JavaScript enabled to view it.
St. Joseph's Hospital & Medical Center - Barrow Neurological Institute
Phoenix, AZ
Ram Narayan, MD Stacey Lent, CCRC
This email address is being protected from spambots. You need JavaScript enabled to view it.
Cedars-Sinai Medical Center
Los Angeles, CA
Nancy Sicotte, MD Cedars-Sinai MS Research Coordinator
This email address is being protected from spambots. You need JavaScript enabled to view it.
University of California, Los Angeles
Los Angeles, CA
Barbara Giesser, MD William Swearingen
This email address is being protected from spambots. You need JavaScript enabled to view it.
Dignity Health Medical Foundation
Sacramento, CA
Sabeen Lulu, MD Lucy Ng, MA, CCRC
This email address is being protected from spambots. You need JavaScript enabled to view it.
University of California, San Diego
San Diego, CA
Jennifer S. Graves, MD, PhD, MAS Jacqueline Alim
This email address is being protected from spambots. You need JavaScript enabled to view it.
University of California, San Francisco
San Francisco, CA
Emmanuelle L Waubant, MD, PhD Nisha R. Revirajan, CCRC
This email address is being protected from spambots. You need JavaScript enabled to view it.
Georgetown University
Washington, DC
Carlo Tornatore, MD Alexis Ahmad
This email address is being protected from spambots. You need JavaScript enabled to view it.
Christiana Care Health Services, Inc.
Newark, DE
Jason Silversteen, MD Kathleen, Greenbaum, MSN, RN, CCRC, CDE
This email address is being protected from spambots. You need JavaScript enabled to view it.
University of Florida
Gainesville, FL
Tirisham Gyang, MD Victoria Hope
This email address is being protected from spambots. You need JavaScript enabled to view it.
University of Miami
Miami, FL
Leticia Tornes, MD Gloria Rodriguez
This email address is being protected from spambots. You need JavaScript enabled to view it.
University of South Florida Health
Tampa, FL
Derrick Robertson, MD Angela Aungst
This email address is being protected from spambots. You need JavaScript enabled to view it.
Rush University Medical Center
Chicago, IL
Michael Ko, MD Rosemarie R. Baligod, RN, BSN
This email address is being protected from spambots. You need JavaScript enabled to view it.
The University of Kansas Medical Center (KUMC)
Kansas City, KS
Sharon Lynch, MD Lisa Schmidt, LPN
This email address is being protected from spambots. You need JavaScript enabled to view it.
Norton Neurology MS Services
Louisville, KY
Geeta Ganesh, MD Deborah Lockridge, RN, BSN, MSCN, CCRC
This email address is being protected from spambots. You need JavaScript enabled to view it.
University of Louisville
Louisville, KY
Kristi Nord, MD Angela Siegwald
This email address is being protected from spambots. You need JavaScript enabled to view it.
Massachusetts General Hospital
Boston, MA
Eric Klawiter, MD, MSc Andrew Russp
This email address is being protected from spambots. You need JavaScript enabled to view it.
University of Massachusetts Medical School
Worcester, MA
Peter Riskind, MD Shaukat Soofi, RN, BSc
This email address is being protected from spambots. You need JavaScript enabled to view it.
The Johns Hopkins Hospital
Baltimore, MD
Ellen Mowry, MD, MCR and Scott Newsome, DO Jen Chalayon
This email address is being protected from spambots. You need JavaScript enabled to view it.
University of Maryland, Baltimore
Baltimore, MD
Daniel Harrison, MD Kerry Naunton, RN, MSCN, CCRC
This email address is being protected from spambots. You need JavaScript enabled to view it.
University of Michigan
Ann Arbor, MI
Yang, Mao-Draayer, MD Michael Hadden
This email address is being protected from spambots. You need JavaScript enabled to view it.
Wayne State University
Detroit, MI
Evanthia Bernitsas, MD Melody Hackett
This email address is being protected from spambots. You need JavaScript enabled to view it.
Mayo Clinic
Rochester, MN
W. Oliver Tobin, MB, BCh, BAO, PhD Katie Dunlay
This email address is being protected from spambots. You need JavaScript enabled to view it.
Billings Clinic
Billings, MT
Sara Qureshi, MD Amy Harmala, LPN
This email address is being protected from spambots. You need JavaScript enabled to view it.
Advanced Neurology Specialists
Great Falls, MT
Dennis Dietrich, MD Laura Armstrong, LPN
This email address is being protected from spambots. You need JavaScript enabled to view it.
Hackensack University Medical Center 
Hackensack, NJ
Krupa Pandey, MD Lee Ifhar, MSc
This email address is being protected from spambots. You need JavaScript enabled to view it.
St, Barnabas Medcial Center
Livingston, NJ
Matthew Tremblay, MD, PhD Isaac Lipsky
This email address is being protected from spambots. You need JavaScript enabled to view it.
Columbia Univeristy Medical Center
New York, NY
Claire Riley, MD Kaho Onomichi
This email address is being protected from spambots. You need JavaScript enabled to view it.
Icahn School of Medicine at Mount Sinai
New York, NY
Aaron Miller, MD Susan Filomena
This email address is being protected from spambots. You need JavaScript enabled to view it.
New York University School of Medicine
New York, NY
Lana Zhovtis Ryerson, MD Dunia Gragui
This email address is being protected from spambots. You need JavaScript enabled to view it.
University of Rochester Medical Center
Rochester, NY
Andrew Goodman, MD Tracy Kraft
This email address is being protected from spambots. You need JavaScript enabled to view it.
Stony Brook University
Stony Brook, NY
Patricia Coyle, MD Jessica Lamb
This email address is being protected from spambots. You need JavaScript enabled to view it.
University of Cincinnati
Cincinnati, OH
Elizabeth Dragan, MD Molly Winters, BSc, CCRP
This email address is being protected from spambots. You need JavaScript enabled to view it.
OhioHealth Research Institute
Columbus, OH
Aaron Boster, MD Fama Diallo
This email address is being protected from spambots. You need JavaScript enabled to view it.
Oklahoma Medical Research Foundation
Oklahoma City, OK
Gabriel Pardo, MD Micki Drake
This email address is being protected from spambots. You need JavaScript enabled to view it.
Providence Health and Services - Oregon
Portland, OR
Kiren Kresa-Reahl, MD Hillary Frey
This email address is being protected from spambots. You need JavaScript enabled to view it.
Geisinger Clinic
Danville, PA
Megan Esch, MD Chelsie Derr
This email address is being protected from spambots. You need JavaScript enabled to view it.
Allegheny Health Network Research Institute
Pittsburgh, PA
Troy Desai, MD Mary Fetter
This email address is being protected from spambots. You need JavaScript enabled to view it.
Vanderbilt Comprehensive MS Center
Nashville, TN
Siddharama Pawate, MD Jennifer Scott, RN
This email address is being protected from spambots. You need JavaScript enabled to view it.
Baylor Scott and White Health
Dallas, TX
Annette F. Okai, MD Rowan Teboh
This email address is being protected from spambots. You need JavaScript enabled to view it.
Central Texas Neurology Consultants
Round Rock, TX
Edward J. Fox, MD, PhD Juan Ramirez
This email address is being protected from spambots. You need JavaScript enabled to view it.
University of Utah
Salt Lake City, UT
John W. Rose, MD Ka Ho Wong
This email address is being protected from spambots. You need JavaScript enabled to view it.
Neurology Consultants of Tidewater
Norfolk, VA
Ingrid Loma-Miller, MD Veda Byrd
This email address is being protected from spambots. You need JavaScript enabled to view it.
The University of Vermont and State Agricultural College
Burlington, VT
Andrew Solomon, MD Jane Low, MPA, CCRC
This email address is being protected from spambots. You need JavaScript enabled to view it.
University of Washington
Seattle, WA
Gloria von Geldern, MD Elisa McGee
This email address is being protected from spambots. You need JavaScript enabled to view it.